{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:24:52Z","timestamp":1787678692513,"version":"build-2784847793"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bioorg.2023.106924","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T23:03:34Z","timestamp":1697670214000},"page":"106924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["New phenothiazine conjugates as apoptosis inducing agents: Design, synthesis, In-vitro anti-cancer screening and 131I-radiolabeling for in-vivo evaluation"],"prefix":"10.1016","volume":"141","author":[{"given":"Mona O.","family":"Sarhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Haffez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosaiba A.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwan S.","family":"El-Haggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa A.","family":"Zaghary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106924_b0005","unstructured":"C. GM., The Cell: A Molecular Approach, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK9963\/ 2000."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106924_b0010.1","doi-asserted-by":"crossref","unstructured":"J. Ferlay, M. Colombet, I. Soerjomataram, D.M. Parkin, M. Pi\u00f1eros, A. Znaor, F. Bray, Cancer statistics for the year 2020: An overview, 149","DOI":"10.1002\/ijc.33588"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106924_b0010.2","doi-asserted-by":"crossref","unstructured":"(4) (2021) 778-789 doi: https:\/\/doi.org\/10.1002\/ijc.33588.","DOI":"10.1002\/ijc.33588"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0015","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185","volume":"71","author":"Sung","year":"2021","journal-title":"Countries"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106924_b0020","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1245\/s10434-022-12151-6","article-title":"GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists","volume":"29","author":"Deo","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bioorg.2023.106924_b0025","doi-asserted-by":"crossref","unstructured":"Z. Ding, M. Zhou, C. Zeng, Recent advances in isatin hybrids as potential anticancer agents, 353(3) (2020) 1900367 doi:https:\/\/doi.org\/10.1002\/ardp.201900367.","DOI":"10.1002\/ardp.201900367"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106924_b0030","doi-asserted-by":"crossref","first-page":"16852","DOI":"10.3390\/molecules200916852","article-title":"Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine\u2019s tool box","volume":"20","author":"Martins","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cmdc.201200355","article-title":"Thiadiazole\u2014A promising structure in medicinal chemistry","volume":"8","author":"Li","year":"2013","journal-title":"ChemMedChem"},{"issue":"24","key":"10.1016\/j.bioorg.2023.106924_b0040","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals: miniperspective","volume":"57","author":"Vitaku","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejmech.2019.07.043","article-title":"Role of sulphur-heterocycles in medicinal chemistry: An update","volume":"180","author":"Pathania","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0050","article-title":"A review: Medicinally important nitrogen sulphur containing heterocycles","volume":"14","author":"Sharma","year":"2020","journal-title":"Open Med. Chem. J."},{"issue":"14","key":"10.1016\/j.bioorg.2023.106924_b0055","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist\u2019s guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0060","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/molecules25081909","article-title":"A review on recent advances in nitrogen-containing molecules and their biological applications","volume":"25","author":"Kerru","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0065","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.ejmech.2011.05.013","article-title":"Recent progress in biological activities of synthesized phenothiazines","volume":"46","author":"Pluta","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0070","doi-asserted-by":"crossref","unstructured":"B. Morak-M\u0142odawska, M. Jele\u0144, K. Pluta, Phenothiazines Modified with the Pyridine Ring as Promising Anticancer Agents, 11(3) (2021) 206.","DOI":"10.3390\/life11030206"},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2023.106924_b0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2010.08.045","article-title":"Multiple non-psychiatric effects of phenothiazines: a review","volume":"648","author":"Sudeshna","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:22:3:189","article-title":"Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines","volume":"22","author":"Gil-Ad","year":"2004","journal-title":"J. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/CAD.0b013e32832ec041","article-title":"The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells","volume":"20","author":"Yde","year":"2009","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106924_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11164-018-3594-7","article-title":"Microwave-assisted and thermal synthesis of nanosized thiazolyl-phenothiazine derivatives and their biological activities","volume":"45","author":"Alsharekh","year":"2019","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2023.106924_b0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2017.04.028","article-title":"Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules","volume":"134","author":"Ghorab","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10637-018-0682-x","article-title":"Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells","volume":"37","author":"Liu","year":"2019","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bioorg.2023.106924_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.131984","article-title":"Enaminones as building blocks in drug development: Recent advances in their chemistry, synthesis, and biological properties","volume":"83","author":"Amaye","year":"2021","journal-title":"Tetrahedron"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106924_b0110","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1021\/mp500173s","article-title":"Positron emission tomography image-guided drug delivery: current status and future perspectives","volume":"11","author":"Chakravarty","year":"2014","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/tx300050f","article-title":"Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?","volume":"25","author":"Penner","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106924_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020594","article-title":"Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging","volume":"6","author":"Vasquez","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106924_b0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cmmi.1530","article-title":"Radiolabeling approaches of nanoparticles with 99mTc","volume":"8","author":"Psimadas","year":"2013","journal-title":"Contrast Media Mol. Imaging"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106924_b0130","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1080\/03639045.2017.1323911","article-title":"Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons","volume":"43","author":"Boschi","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106924_b0135","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1134\/S1070428019090227","article-title":"Comparative study between thermal heating and microwave-assisted synthesis for new series of phenothiazine derivatives","volume":"55","author":"Bumander","year":"2019","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0140","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejmech.2014.12.010","article-title":"Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents","volume":"90","author":"Eldehna","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106924_b0145","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1021\/acs.joc.6b01110","article-title":"Conjugate addition of 3-Buytn-2-one to anilines in ethanol: alkene geometric insights through in situ FTIR monitoring","volume":"81","author":"Chisholm","year":"2016","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-4-18","article-title":"Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines","volume":"4","author":"Eng","year":"2011","journal-title":"BMC Med. Genomics"},{"issue":"15","key":"10.1016\/j.bioorg.2023.106924_b0155","first-page":"4814","article-title":"Marine cyanobacteria as sources of lead anticancer compounds: A review of families of metabolites with cytotoxic","volume":"27","author":"Robles-Ba\u00f1uelos","year":"2022","journal-title":"Antiprolif. Antineopl. Eff."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/bioinformatics\/btv529","article-title":"Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel","volume":"32","author":"Cort\u00e9s-Ciriano","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2023.106924_b0165","doi-asserted-by":"crossref","unstructured":"R.C. Leif, Practical flow cytometry, by Howard M. Shapiro. Alan R. Liss, New York, 1985, 295 pages, $49.50, Wiley Online Library, 1986.","DOI":"10.1002\/cyto.990070119"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106924_b0170","first-page":"955","article-title":"The combined use of phenothiazines and statins strongly affects doxorubicin-resistance, apoptosis, and Cox-2 activity in colon","volume":"20","author":"\u015aroda-Pomianek","year":"2019","journal-title":"Cancer Cells"},{"key":"10.1016\/j.bioorg.2023.106924_b0175","doi-asserted-by":"crossref","unstructured":"G. Spengler, \u00c1. Csonka, J. Molnar, L.J.A.r. Amaral, The anticancer activity of the old neuroleptic phenothiazine-type drug thioridazine, 36(11) (2016) 5701-5706.","DOI":"10.21873\/anticanres.11153"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106924_b0180","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00044-018-2242-5","article-title":"Cytotoxicity, apoptosis, and QSAR studies of phenothiazine derived methoxylated chalcones as anticancer drug candidates","volume":"27","author":"Gul","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10495-020-01594-5","article-title":"Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma","volume":"25","author":"Omoruyi","year":"2020","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","article-title":"Apoptosis in cancer","volume":"21","author":"Lowe","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioorg.2023.106924_b0195","doi-asserted-by":"crossref","unstructured":"M. Skonieczna, A. Kasprzycka, M. Jele\u0144, B. Morak-M\u0142odawska, Tri- and Pentacyclic Azaphenothiazine as Pro-Apoptotic Agents in Lung Carcinoma with a Protective Potential to Healthy Cell Lines, 27(16) (2022) 5255.","DOI":"10.3390\/molecules27165255"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0200","first-page":"199","article-title":"Regulation of recording and gene expression in eukaryotes","volume":"1","author":"Phillips","year":"2008","journal-title":"Nature Professional"},{"key":"10.1016\/j.bioorg.2023.106924_b0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biopha.2018.06.123","article-title":"ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine","volume":"106","author":"Seervi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106924_b0210","first-page":"3278","article-title":"Trifluoperazine induces apoptosis through the upregulation of Bax\/Bcl-2 and downregulated phosphorylation of AKT in mesangial cells and improves renal function in lupus nephritis mice","volume":"41","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bioorg.2023.106924_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118578","article-title":"What are the immune responses during the growth of Ehrlich's tumor in ascitic and solid form?","volume":"264","author":"Feitosa","year":"2021","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106924_b0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/oxfordjournals.annonc.a058872","article-title":"Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study","volume":"5","author":"Langdon","year":"1994","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0225","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1158\/2159-8290.CD-20-0116","article-title":"Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR\u2013MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLCAmivantamab in NSCLC with EGFR Exon20ins","volume":"10","author":"Yun","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2023.106924_b0230","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00044-018-2242-5","article-title":"Cytotoxicity, apoptosis, and QSAR studies of phenothiazine derived methoxylated chalcones as anticancer drug candidates","volume":"27","author":"Gul","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2023.106924_b0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10495-020-01594-5","article-title":"Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma","volume":"25","author":"Omoruyi","year":"2020","journal-title":"Apoptosis"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106924_b0240","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/ijms20123047","article-title":"Indirect radioiodination of DARPin G3 using N-succinimidyl-para-iodobenzoate improves the contrast of HER2 molecular imaging","volume":"20","author":"Vorobyeva","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0245","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acs.molpharmaceut.8b00922","article-title":"Comparative evaluation of two DARPin variants: effect of affinity, size, and label on tumor targeting properties","volume":"16","author":"Deyev","year":"2019","journal-title":"Mol. Pharm."},{"issue":"D1","key":"10.1016\/j.bioorg.2023.106924_b0250","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.bioorg.2023.106924_b0255","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: streamlining access to drug discovery data and utilities","volume":"43","author":"Davies","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bioorg.2023.106924_b0260","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2023.106924_b0265","unstructured":"D. Gianni, N. Nicolas, H. Zhang, C. Der Mardirossian, J. Kister, L. Martinez, J. Ferguson, W. Roush, S. Brown, G.J.P.R.f.t.N.M.L.P. Bokoch, Optimization and characterization of an inhibitor for NADPH oxidase 1 (NOX-1), (2011)."},{"key":"10.1016\/j.bioorg.2023.106924_b0270","doi-asserted-by":"crossref","unstructured":"D. Gianni, N. Taulet, H. Zhang, C. DerMardirossian, J. Kister, L. Martinez, W.R. Roush, S.J. Brown, G.M. Bokoch, H.J.A.c.b. Rosen, A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells, 5(10) (2010) 981-993.","DOI":"10.1021\/cb100219n"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0275","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2007.03.027","article-title":"Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy","volume":"43","author":"Lambeth","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0280","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/1440-1681.12238","article-title":"Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets","volume":"41","author":"Harrison","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"31","key":"10.1016\/j.bioorg.2023.106924_b0285","doi-asserted-by":"crossref","first-page":"51888","DOI":"10.18632\/oncotarget.17128","article-title":"Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews","volume":"8","author":"G\u00e0o","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106924_b0290","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/CS20140542","article-title":"NADPH oxidases and cancer","volume":"128","author":"Roy","year":"2015","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106924_b0295","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.freeradbiomed.2007.08.029","article-title":"Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach","volume":"43","author":"Tominaga","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106924_b0300","doi-asserted-by":"crossref","first-page":"e101735","DOI":"10.1371\/journal.pone.0101735","article-title":"Induction of cancer stem cell properties in colon cancer cells by defined factors","volume":"9","author":"Oshima","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2004.08.031","article-title":"Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon","volume":"221","author":"Fukuyama","year":"2005","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106924_b0310","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/bph.13532","article-title":"Therapeutic potential of NADPH oxidase 1\/4 inhibitors","volume":"174","author":"Teixeira","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106924_b0315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/ars.2020.8046","article-title":"Inhibiting the Activity of NADPH Oxidase in Cancer","volume":"33","author":"Konat\u00e9","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bioorg.2023.106924_b0320","doi-asserted-by":"crossref","unstructured":"The NADPH Oxidase Family and Its Inhibitors, Antioxidants & redox signaling 33(5) (2020) 332-353 doi:10.1089\/ars.2019.7915.","DOI":"10.1089\/ars.2019.7915"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0325","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/med.21734","article-title":"Small molecules regulating reactive oxygen species homeostasis for cancer therapy","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"23","key":"10.1016\/j.bioorg.2023.106924_b0330","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1016\/j.bmc.2011.10.016","article-title":"Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4\/Nox1 inhibitors","volume":"19","author":"Gaggini","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0335","article-title":"Amido thiadiazole derivatives as nadph oxidase inhibitors","author":"Machin","year":"2016","journal-title":"Google Patents"},{"key":"10.1016\/j.bioorg.2023.106924_b0340","article-title":"Amido thiadiazole derivatives as NADPH oxidase inhibitors","author":"Machin","year":"2018","journal-title":"Google Patents"},{"key":"10.1016\/j.bioorg.2023.106924_b0345","article-title":"Amido thiadiazole derivatives as nadph oxidase inhibitors","author":"Machin","year":"2019","journal-title":"Google Patents"},{"key":"10.1016\/j.bioorg.2023.106924_b0350","article-title":"Pyrazoline dione derivatives as NADPH oxidase inhibitors","author":"Page","year":"2016","journal-title":"Google Patents"},{"key":"10.1016\/j.bioorg.2023.106924_b0355","article-title":"Pyrazoline dione derivatives as nadph oxidase inhibitors","author":"Page","year":"2011","journal-title":"Google Patents"},{"issue":"21","key":"10.1016\/j.bioorg.2023.106924_b0360","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1021\/jm100773e","article-title":"First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis","volume":"53","author":"Laleu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0365","doi-asserted-by":"crossref","first-page":"e0204378","DOI":"10.1371\/journal.pone.0204378","article-title":"2nd, The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs","volume":"14","author":"Fan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2023.106924_b0370","doi-asserted-by":"crossref","unstructured":"E.A. Orellana, A.L.J.B.-p. Kasinski, Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation, 6(21) (2016) e1984-e1984.","DOI":"10.21769\/BioProtoc.1984"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0375","first-page":"85","article-title":"Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel","volume":"32","author":"Cort\u00e9s-Ciriano","year":"2016","journal-title":"Bioinformatics (oxford, England)"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106924_b0380","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1734-1140(10)70272-3","article-title":"Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank","volume":"62","author":"Pluta","year":"2010","journal-title":"Pharmacol. Rep. PR"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106924_b0385","first-page":"506","article-title":"Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer","volume":"26","author":"Abdelaal","year":"2021","journal-title":"Therapy"},{"issue":"16","key":"10.1016\/j.bioorg.2023.106924_b0390","first-page":"9442","article-title":"Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In","volume":"23","author":"Abdelaal","year":"2022","journal-title":"Vitro Approach"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106924_b0395","first-page":"402","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods (San Diego","volume":"25","author":"Livak","year":"2001","journal-title":"Calif.)"},{"issue":"7","key":"10.1016\/j.bioorg.2023.106924_b0400","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.intimp.2010.04.023","article-title":"Effect of thalidomide dithiocarbamate analogs on the intercellular adhesion molecule-1 expression","volume":"10","author":"Guirgis","year":"2010","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0405","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3390\/molecules26082273","article-title":"Discovery of new coumarin-based lead with potential anticancer, CDK4 inhibition and selective radiotheranostic effect: Synthesis, 2D & 3D QSAR, molecular dynamics, in vitro cytotoxicity, radioiodination, and biodistribution studies","volume":"26","author":"Sarhan","year":"2021","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.bioorg.2023.106924_b0410","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.3390\/ijms23169442","article-title":"Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach","volume":"23","author":"Abdelaal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106924_b0415","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0892-0362(03)00073-4","article-title":"teratology, Factors affecting grip strength testing","volume":"25","author":"Maurissen","year":"2003","journal-title":"Neurotoxicol. Teratol."},{"issue":"22","key":"10.1016\/j.bioorg.2023.106924_b0420","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1039\/D0DT00845A","article-title":"t Bu 4 octapa-alkyl-NHS for metalloradiopeptide preparation","volume":"49","author":"Li","year":"2020","journal-title":"Dalton Trans."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0425","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13321-015-0052-z","article-title":"When drug discovery meets web search: Learning to Rank for ligand-based virtual screening","volume":"7","author":"Zhang","year":"2015","journal-title":"J. Cheminf."},{"key":"10.1016\/j.bioorg.2023.106924_b0430","doi-asserted-by":"crossref","unstructured":"T. Liu, Y. Lin, X. Wen, R.N. Jorissen, M.K. Gilson, BindingDB: a web-accessible database of experimentally determined protein\u2013ligand binding affinities, Nucleic Acids Research 35(suppl_1) (2006) D198-D201 doi:10.1093\/nar\/gkl999 %J Nucleic Acids Research.","DOI":"10.1093\/nar\/gkl999"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0435","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"20","key":"10.1016\/j.bioorg.2023.106924_b0440","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.3390\/ijms21207779","article-title":"Ligand-based pharmacophore modeling, molecular docking, and molecular dynamic studies of dual tyrosine kinase inhibitor of EGFR and VEGFR2","volume":"21","author":"Sangande","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.bioorg.2023.106924_b0450","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/1440-1681.13671","article-title":"Physiology, Possible involvement of apoptosis in the antipsychotics side effects: A mini-review","volume":"49","author":"Osacka","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bioorg.2023.106924_b0455","article-title":"Novel Ziyuglycoside II derivatives inhibit MCF-7 cell proliferation via inducing apoptosis and autophagy","volume":"106752","author":"Zhong","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106638","article-title":"New benzothienopyran and benzothienopyranopyrimidine derivatives as topoisomerase I inhibitors: Design, synthesis, anticancer screening, apoptosis induction and molecular modeling studies","author":"Khalil","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105762","article-title":"Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1, 2, 3-triazole-chalcone conjugates","volume":"123","author":"Othman","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106924_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105689","article-title":"Triterpenoids and meroterpenoids from the edible Ganoderma resinaceum and their potential anti-inflammatory, antioxidant and anti-apoptosis activities","volume":"121","author":"Kou","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106924_b0475","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1016\/j.bmc.2008.05.040","article-title":"Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives","volume":"16","author":"Bisi","year":"2008","journal-title":"Biorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106924_b0480","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.bmc.2016.04.001","article-title":"Studies on phenothiazines: New microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents","volume":"24","author":"Ghinet","year":"2016","journal-title":"Biorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106924_b0485","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.bmc.2013.04.034","article-title":"Synthesis and pharmacological investigation of new N-hydroxyalkyl-2-aminophenothiazines exhibiting marked MDR inhibitory effect","volume":"21","author":"Tak\u00e1cs","year":"2013","journal-title":"Biorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2023.106924_b0490","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1016\/j.bmcl.2012.09.030","article-title":"Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors","volume":"22","author":"Baciu-Atudosie","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106924_b0495","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bmcl.2014.02.012","article-title":"4, 5-Dihydro-1H-pyrazolo [3, 4-d] pyrimidine containing phenothiazines as antitubercular agents","volume":"24","author":"Siddiqui","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2023.106924_b0500","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.bmcl.2015.09.008","article-title":"Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds","volume":"25","author":"Dumitriu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bmcl.2012.10.135","article-title":"Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents","volume":"23","author":"Abuhaie","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2023.106924_b0510","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.bmcl.2019.07.023","article-title":"Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine\/phenothiazine hybrid constructs targeting protein phosphatase 2A","volume":"29","author":"Garsi","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106924_b0515","doi-asserted-by":"crossref","unstructured":"L.R. Morgan, A.H. Rodgers, B.W. LeBlanc, S.M. Boue, Y. Yang, B.S. Jursic, R.B.J.B. Cole, m.c. letters, Anticancer properties for 4, 4\u2032-dihydroxybenzophenone-2, 4-dinitrophenylhydrazone (A-007)\/3, 7-diaminophenothiazin-5-ium double salts, Bioorg. Med. Chem. Lett. 11(16) (2001) 2193-2195.","DOI":"10.1016\/S0960-894X(01)00408-5"},{"key":"10.1016\/j.bioorg.2023.106924_b0520","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes: phenothiazines and leukemia","volume":"53","author":"Zhelev","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106924_b0525","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/biom12101360","article-title":"Antipsychotic Drug Fluphenazine against Human Cancer Cells","volume":"12","author":"Duarte","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.bioorg.2023.106924_b0530","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1038\/cddis.2011.62","article-title":"Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of \u03b3H2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation","volume":"2","author":"Zong","year":"2011","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0535","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/antibiotics12010137","article-title":"Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases","volume":"12","author":"R\u00e1cz","year":"2023","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106924_b0540","first-page":"435","article-title":"Enhancement of immune response by phenothiazine administration in vivo","volume":"7","author":"Ghosh","year":"1993","journal-title":"In Vivo (athens, Greece)"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106924_b0545","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","article-title":"Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus","volume":"47","author":"Kaatz","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106924_b0550","first-page":"943","article-title":"Differential effect of phenothiazines on MRP1 and P-glycoprotein activity","volume":"23","author":"Weso\u0142owska","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.bioorg.2023.106924_b0555","article-title":"The role of phenothiazine derivatives in autophagy regulation: A systematic review","author":"Otr\u0119ba","year":"2022","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106924_b0560","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/life11040365","article-title":"Inhibition of autophagy enhances the antitumor effect of thioridazine in acute lymphoblastic leukemia cells","volume":"11","author":"Colturato-Kido","year":"2021","journal-title":"Life"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106924_b0565","first-page":"5983","article-title":"Possible biological and clinical applications of phenothiazines","volume":"37","author":"Varga","year":"2017","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106924_b0570","doi-asserted-by":"crossref","first-page":"e0268635","DOI":"10.1371\/journal.pone.0268635","article-title":"Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells","volume":"17","author":"Manoharan","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0575","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jat.4046","article-title":"In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review","volume":"41","author":"Otr\u0119ba","year":"2021","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106924_b0580","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7150\/jca.34847","article-title":"The antipsychotic agent sertindole exhibited antiproliferative activities by inhibiting the STAT3 signaling pathway in human gastric cancer cells","volume":"11","author":"Dai","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bioorg.2023.106924_b0585","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopha.2018.06.170","article-title":"Pharmacotherapy, Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo\/Dx in the presence of newly synthesized phenothiazine derivatives","volume":"106","author":"\u015aroda-Pomianek","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2023.106924_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/4163274","article-title":"Antipsychotic drugs reverse MK801-inhibited cell migration and F-actin condensation by modulating the rho signaling pathway in B35 cells","author":"Chen","year":"2020","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.bioorg.2023.106924_b0595","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s11427-013-4561-6","article-title":"Potential antitumor mechanisms of phenothiazine drugs","volume":"56","author":"Qi","year":"2013","journal-title":"Sci. China Life Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106924_b0600","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/tra.12272","article-title":"Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis","volume":"16","author":"Daniel","year":"2015","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0605","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s42003-022-03172-8","article-title":"Pleiotropic actions of phenothiazine drugs are detrimental to Gram-negative bacterial persister cells","volume":"5","author":"Mohiuddin","year":"2022","journal-title":"Comm. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0610","doi-asserted-by":"crossref","first-page":"e0189950","DOI":"10.1371\/journal.pone.0189950","article-title":"Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity","volume":"13","author":"Nehme","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106924_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101012","article-title":"Phenothiazines alter plasma membrane properties and sensitize cancer cells to injury by inhibiting annexin-mediated repair","volume":"297","author":"Heitmann","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106924_b0620","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: The bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"22","key":"10.1016\/j.bioorg.2023.106924_b0625","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1038\/s41388-019-0702-0","article-title":"NF-\u03baB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells","volume":"38","author":"Echizen","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106924_b0630","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3892\/or.2016.5068","article-title":"Inhibition of Nox1 induces apoptosis by attenuating the AKT signaling pathway in oral squamous cell carcinoma cell lines","volume":"36","author":"Ito","year":"2016","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106924_b0635","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1349-7006.2006.00343.x","article-title":"PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma","volume":"97","author":"Kozaki","year":"2006","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-01837-6","article-title":"NOX1 inhibition attenuates the development of a pro-tumorigenic environment in experimental hepatocellular carcinoma","volume":"40","author":"Vandierendonck","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106924_b0645","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800265","article-title":"Inhibition of Host NOX1 Blocks Tumor Growth and Enhances Checkpoint Inhibitor\u2013based Immunotherapy","volume":"2","author":"Stalin","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bioorg.2023.106924_b0650","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jare.2021.07.003","article-title":"Pegylation of phenothiazine\u2013A synthetic route towards potent anticancer drugs","volume":"37","author":"Cibotaru","year":"2022","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106924_b0655","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/molecules27010276","article-title":"Development of phenothiazine hybrids with potential medicinal interest: a review","volume":"27","author":"Posso","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106924_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105653","article-title":"Biological screening and radiolabeling of raptinal as a potential anticancer novel drug in hepatocellular carcinoma model","volume":"158","author":"Haffez","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106924_b0665","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/cbt.5.3.2431","article-title":"Biodistribution and localization of iodine-131 labeled Metuximab in patients with hepatocellular carcinoma","volume":"5","author":"Zhang","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioorg.2023.106924_b0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-019-2924-z","article-title":"Antitumor effect of 131 I-Labeled Anti-VEGFR2 targeted mesoporous silica nanoparticles in anaplastic thyroid cancer","volume":"14","author":"Zhang","year":"2019","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bioorg.2023.106924_b0675","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11805-009-0256-y","article-title":"Biodistribution and anti-tumor activities of the 131 I-labeled rituximab in nude mice bearing human Burkitt\u2019s lymphoma","volume":"6","author":"Zuo","year":"2009","journal-title":"Clin. Oncol. Cancer Res."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106924_b0680","first-page":"3315","article-title":"Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice","volume":"31","author":"Andratschke","year":"2011","journal-title":"Anticancer Res"},{"issue":"03","key":"10.1016\/j.bioorg.2023.106924_b0685","first-page":"173","article-title":"P.J.W.J.o.N.M. Geramifar, Gastrointestinal side effects of the radioiodine therapy for the patients with differentiated thyroid carcinoma two days after prescription, World","volume":"15","author":"Pashnehsaz","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106924_b0690","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/cancers14102505","article-title":"Radioactive iodine treatment for thyroid cancer patients increases the risk of long-term gastrointestinal disorders: a nationwide population-based cohort analysis","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:57:45Z","timestamp":1758617865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823005850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":139,"alternative-id":["S0045206823005850"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106924","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New phenothiazine conjugates as apoptosis inducing agents: Design, synthesis, In-vitro anti-cancer screening and 131I-radiolabeling for in-vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106924"}}